Update shared on 20 Nov 2025
Fair value Decreased 0.42%Narrative Update on Suzano
Analysts have slightly lowered their price target for Suzano from $74.18 to $73.86. This adjustment reflects modest changes to revenue growth, profit margin, and future earnings expectations.
What's in the News
- Suzano S.A. will hold a board meeting on August 28, 2025, to discuss a tender offer for bonds. (Key Developments)
- Suzano S.A. has been added to the Brazil Valor BM&FBOVESPA Index. (Key Developments)
- A board meeting is scheduled for August 18, 2025, to approve and consider the issuance of bonds, authorize related corporate guarantees, and address other business matters. (Key Developments)
Valuation Changes
- Fair Value: The fair value estimate has decreased slightly from R$74.18 to R$73.86.
- Discount Rate: The discount rate has fallen marginally, moving from 26.72% to 26.59%.
- Revenue Growth: Projected revenue growth has risen modestly, increasing from 9.03% to 10.27%.
- Net Profit Margin: The net profit margin has improved slightly, from 14.37% to 14.96%.
- Future P/E: The forward price-to-earnings ratio has decreased, moving from 19.35x to 17.88x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.